N Engl J Med 380 (13): 1226-1234, 2019.[PUBMED Abstract] Vidula N, Yau C, Rugo HS: Trop2 gene expression (Trop2e) in primary breast cancer (BC): Correlations with clinical and tumor characteristics.
[Abstract] J Clin Oncol 35 (15 Suppl): A-1075, 2017.
Rugo HS, Bardia A, Marm√© F, et al.: Sacituzumab Govitecan in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer.
J Clin Oncol 40 (29): 3365-3376, 2022.[PUBMED Abstract] Modi S, Park H, Murthy RK, et al.: Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study.